TY - JOUR
T1 - A multidisciplinary nephrogenetic referral clinic for children and adults—diagnostic achievements and insights
AU - Pode-Shakked, Ben
AU - Ben-Moshe, Yishay
AU - Barel, Ortal
AU - Regev, Lilach C.
AU - Kagan, Maayan
AU - Eliyahu, Aviva
AU - Marek-Yagel, Dina
AU - Atias-Varon, Danit
AU - Lahav, Einat
AU - Issler, Naomi
AU - Shlomovitz, Omer
AU - Semo Oz, Rotem
AU - Kol, Nitzan
AU - Mor, Nofar
AU - Bar-Joseph, Ifat
AU - Khavkin, Yulia
AU - Javasky, Elisheva
AU - Beckerman, Pazit
AU - Greenberg, Meidad
AU - Volovelsky, Oded
AU - Borovitz, Yael
AU - Davidovits, Miriam
AU - Haskin, Orly
AU - Alfandary, Hadas
AU - Levi, Shely
AU - Kaidar, Maital
AU - Katzir, Ze’ev
AU - Angel-Korman, Avital
AU - Becker-Cohen, Rachel
AU - Ben-Shalom, Efrat
AU - Leiba, Adi
AU - Mor, Eytan
AU - Dagan, Amit
AU - Pessach, Itai M.
AU - Lotan, Danny
AU - Shashar, Moshe
AU - Anikster, Yair
AU - Raas-Rothschild, Annick
AU - Rechavi, Gideon
AU - Dekel, Benjamin
AU - Vivante, Asaf
N1 - Publisher Copyright:
© 2021, The Author(s), under exclusive licence to International Pediatric Nephrology Association.
PY - 2022/7
Y1 - 2022/7
N2 - Background: Genetic kidney diseases contribute a significant portion of kidney diseases in children and young adults. Nephrogenetics is a rapidly evolving subspecialty; however, in the clinical setting, increased use of genetic testing poses implementation challenges. Consequently, we established a national nephrogenetics clinic to apply a multidisciplinary model. Methods: Patients were referred from different pediatric or adult nephrology units across the country if their primary nephrologist suspected an undiagnosed genetic kidney disease. We determined the diagnostic rate and observed the effect of diagnosis on medical care. We also discuss the requirements of a nephrogenetics clinic in terms of logistics, recommended indications for referral, and building a multidisciplinary team. Results: Over 24 months, genetic evaluation was completed for a total of 74 unrelated probands, with an age range of 10 days to 72 years. The most common phenotypes included congenital anomalies of the kidneys and urinary tract, nephrotic syndrome or unexplained proteinuria, nephrocalcinosis/nephrolithiasis, tubulopathies, and unexplained kidney failure. Over 80% of patients were referred due to clinical suspicion of an undetermined underlying genetic diagnosis. A molecular diagnosis was reached in 42/74 probands, yielding a diagnostic rate of 57%. Of these, over 71% of diagnoses were made via next generation sequencing (gene panel or exome sequencing). Conclusions: We identified a substantial fraction of genetic kidney etiologies among previously undiagnosed individuals which influenced subsequent clinical management. Our results support that nephrogenetics, a rapidly evolving field, may benefit from well-defined multidisciplinary co-management administered by a designated team of nephrologist, geneticist, and bioinformatician. Graphical abstract: A higher resolution version of the Graphical abstract is available as Supplementary information [Figure not available: see fulltext.].
AB - Background: Genetic kidney diseases contribute a significant portion of kidney diseases in children and young adults. Nephrogenetics is a rapidly evolving subspecialty; however, in the clinical setting, increased use of genetic testing poses implementation challenges. Consequently, we established a national nephrogenetics clinic to apply a multidisciplinary model. Methods: Patients were referred from different pediatric or adult nephrology units across the country if their primary nephrologist suspected an undiagnosed genetic kidney disease. We determined the diagnostic rate and observed the effect of diagnosis on medical care. We also discuss the requirements of a nephrogenetics clinic in terms of logistics, recommended indications for referral, and building a multidisciplinary team. Results: Over 24 months, genetic evaluation was completed for a total of 74 unrelated probands, with an age range of 10 days to 72 years. The most common phenotypes included congenital anomalies of the kidneys and urinary tract, nephrotic syndrome or unexplained proteinuria, nephrocalcinosis/nephrolithiasis, tubulopathies, and unexplained kidney failure. Over 80% of patients were referred due to clinical suspicion of an undetermined underlying genetic diagnosis. A molecular diagnosis was reached in 42/74 probands, yielding a diagnostic rate of 57%. Of these, over 71% of diagnoses were made via next generation sequencing (gene panel or exome sequencing). Conclusions: We identified a substantial fraction of genetic kidney etiologies among previously undiagnosed individuals which influenced subsequent clinical management. Our results support that nephrogenetics, a rapidly evolving field, may benefit from well-defined multidisciplinary co-management administered by a designated team of nephrologist, geneticist, and bioinformatician. Graphical abstract: A higher resolution version of the Graphical abstract is available as Supplementary information [Figure not available: see fulltext.].
KW - Inherited kidney diseases
KW - Nephrogenetics
KW - Next generation sequencing
KW - Renal genetics
KW - Whole exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85122389077&partnerID=8YFLogxK
U2 - 10.1007/s00467-021-05374-4
DO - 10.1007/s00467-021-05374-4
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34993602
AN - SCOPUS:85122389077
SN - 0931-041X
VL - 37
SP - 1623
EP - 1646
JO - Pediatric Nephrology
JF - Pediatric Nephrology
IS - 7
ER -